v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net loss $ (6,202,164) $ (151,677)
Adjustment to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 611,502 20,422
Non-cash interest earned on short-term investments (4,324)
Non-cash interest expense – related parties 50,785
Non-cash interest earned on promissory notes – related party (59,178)
Changes in operating assets and liabilities:    
Tax incentive receivable (933,250)
Prepaid expenses 198,464
Accounts payable 2,165,548
Accrued expenses and other current liabilities 3,467,666
Net cash used in operating activities (704,951) (131,255)
Cash flows from investing activities:    
Purchase of short-term investments (10,063,562)
Net cash used in investing activities (10,063,562)
Cash flows from financing activities:    
Proceeds from issuance of common stock 20,000,000
Net cash provided by financing activities 20,000,000
Net increase (decrease) in cash and cash equivalents 9,231,487 (131,255)
Cash and cash equivalents at beginning of year 28,417,310 800,728
Cash and cash equivalents at end of period 37,648,797 669,473
Supplemental disclosure of cash flow information:    
Stock issuance costs included in accounts payable and accrued expenses 1,506,000
Interest receivable on promissory note issued to stockholder $ 59,178